ECOR vs NRXS: stock comparison and AI forecast
Electrocore, Inc. (ECOR) and Neuraxis, Inc (NRXS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ECOR Electrocore, Inc.
- Price
- $8.80 +40.4% · 6M
- Market Cap
- $79M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NRXS Neuraxis, Inc
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ECOR and NRXS have similar market capitalizations ($79M and $77M).
- ECOR turns -33.5% of its revenue into net income, against -144.4% for NRXS.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ECOR | NRXS |
|---|---|---|
| Market Cap | $79M | $77M |
| P/B Ratio | – | 11.39x |
| EPS | $-1.38 | $-0.92 |
| Book Value/Share | – | $0.54 |
| Revenue/Share | $4.21 | $0.42 |
| FCF/Share | $-1.21 | – |
Profitability & Margins
| Metric | ECOR | NRXS |
|---|---|---|
| ROE | – | -114.0% |
| ROA | -73.6% | -76.8% |
| ROIC | -194.3% | -111.3% |
| Gross Margin | 87.7% | 85.6% |
| Operating Margin | -33.1% | -144.5% |
| Net Margin | -33.5% | -144.4% |
| EBT Margin | -34.5% | -144.5% |
| Tax Rate | 3.0% | -0.3% |
Financial Health
| Metric | ECOR | NRXS |
|---|---|---|
| Current Ratio | 1.34x | 3.04x |
| Quick Ratio | 0.97x | 2.95x |
| D/E Ratio | – | 0.48x |
| Financial Leverage | – | 1.48x |
| Interest Coverage | -420.5x | -107.3x |
| Working Capital | $4M | $6M |
Cash Flow
| Metric | ECOR | NRXS |
|---|---|---|
| Operating Cash Flow | -$11M | -$6M |
| Free Cash Flow | -$11M | – |
| Capital Spending | -$10K | – |
| FCF/Sales | -28.7% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | ECOR | NRXS |
|---|---|---|
| Asset Turnover | 2.20x | 0.53x |
| Receivables Turnover | 23.4x | 12.3x |
| Inventory Turnover | 1.2x | 2.8x |
| Fixed Assets Turnover | 102.3x | 81.2x |
| Days Sales Outstanding | 16 days | 30 days |
| Days Inventory | 309 days | 132 days |
| Payables Period | 268 days | 376 days |
| Cash Conversion Cycle | 56 days | -215 days |
Income Statement
| Metric | ECOR | NRXS |
|---|---|---|
| Total Revenue | $38M | $5M |
| Operating Income | -$13M | -$8M |
| Net Income | -$13M | -$8M |
| R&D Expense | $3M | $750K |
| SG&A Expense | $43M | $11M |
| Cost of Goods Sold | $5M | $770K |
Dividend & Shareholder Information
| Metric | ECOR | NRXS |
|---|---|---|
| Shares Outstanding | 9M | 13M |
ECOR vs NRXS: stock comparison and AI forecast
Which is bigger, ECOR or NRXS?
ECOR and NRXS have similar market capitalizations ($79M and $77M).
Which one does Intratio's AI model rank higher, ECOR or NRXS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.